From: Tracking of serum lipids from prepuberty to young adulthood: results from the KiGGS cohort study
 | Male (N = 306) | Female (N = 288) | ||||||
---|---|---|---|---|---|---|---|---|
bivariable | multivariable | bivariable | multivariable | |||||
Beta (95% CI) | R2 | Beta (95% CI) | R2 | Beta (95% CI) | R2 | Beta (95% CI) | R2 | |
Baseline non-HDL cholesterol | 0.95 (0.68;1.23)*** | 0.53 | 0.81 (-0.18;1.37)*** | 0.62 | 0.67 (0.50–0.83)*** | 0.28 | 0.67 (0.54;0.79)*** | 0.45 |
BMI z-score in childhood | 0.18 (-0.04;0.41) | 0.04 | 0.06 (-0.01;0.13) | 0.05 (-0.06;0.16) |  < 0.01 | -0.01 (-0.10;0.08) | ||
Difference in BMI z-score to young adulthood | 0.40 (0.18–0.63)*** | 0.17 | 0.28 (0.17;0.39)*** | 0.14 (-0.03;0.30) | 0.02 | 0.17 (0.08;0.25)*** | ||
Smoking in young adulthood | -0.18 (-0.50;0.14) |  < 0.01 | -0.08 (-0.23; 0.08) | 0.21 (-0.15;0.58) | 0.01 | 0.20 (-0.08;0.49) | ||
Alcohol use in young adulthood |  | 0.07 |  |  |  < 0.01 |  | ||
 No | 0.74 (-0.14;1.63) |  | 0.40 (-0.02; 0.82) | -0.09 (-0.25;0.33) |  | 0.24 (-0.14;0.61) | ||
 Moderate | ref |  | ref | ref |  | ref | ||
 At risk | -0.06 (-0.29;0.17) |  | -0.01 (-0.15;0.14) | 0.06 (-0.25;0.36) |  | -0.08 (-0.28; 0.12) | ||
Oral contraceptives use in young adulthood | - | - | - | - | 0.68 (0.44;0.92)*** | 0.16 | 0.67 (0.47;0.87)*** |